Immune checkpoint inhibitors for cutaneous T-cell lymphoma
Current research to overcome T-cell dysfunction in CLL and improve therapies
New insight into the biology of multiple myeloma: from clonal evolution to new treatment options
Targeting ROR1 and a two-drug approach to cure CLL
How is the landscape of Hodgkin lymphoma therapy changing?